eli-002
elicio therapeutics
['amplify-201', 'elicio,(-delicious)', 'elicio']
 showcased the encouraging results from the amplify-201 phase i trial at the ongoing 2023 annual meeting. explore more about the key finding from the amplify-201 trial, at: #cancerresearch #oncology #conference2023 #asco23 #ascoabstracts 
#DelveInsight is a premier Business Consulting and Market Research firm, focused exclusively on the healthcare industry